Skip to main content
. Author manuscript; available in PMC: 2024 Jan 25.
Published in final edited form as: Expert Rev Ophthalmol. 2020 May 14;15(3):145–157. doi: 10.1080/17469899.2020.1762488

Table 4.

Potential Treatment Strategies for GC-induced Ocular Hypertension

• Cortisol Derivatives
  ∘ Tetrahydrocortisol
  ∘ Anecortave acetate
• Tissue Plasminogen Activator
• Gene Therapy
  ∘ GRE-MMP1
  ∘ GRβ